Dexcom | Les Charges D'Exploitation

Prix De L'Action
72.87
Variation Quotidienne
-0.39 -0.53%
Mensuellement
-0.64%
Annuel
-17.49%
Q1 Prévisions
70.81




Les Charges D'Exploitation Changement Date
Abbott USD 9.21B 17M 2025-12
Align Technology USD 822.85M 11.8M 2025-12
AtriCure USD 138.01M 3.95M 2025-12
Avanos Medical USD 156.13M 2.7M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Cooper Companies USD 924.8M 40.2M 2025-09
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Globus Medical USD 886.57M 730.06M 2025-09
Hologic USD 349.4M 447.1M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 1.04B 620.66M 2025-09
J&J USD 18.97B 2.38B 2025-12
Masimo USD 147M 159.4M 2025-09
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 341.54M 6.11M 2025-09
Roche Holding CHF 21.01B 10.84B 2025-12
Solventum Corp USD 4.99B 3.04B 2025-09
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 3.82B 3.22B 2025-09
West Pharmaceutical Services USD 642.5M 2.41B 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12


Dexcom Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.